OWENS & MINOR INC. overview

Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: Consolidated revenue of $2.56 billion Net loss per common share of $(0.37) and adjusted net income per common share of $0.18 $49.3 million in debt pay down and $269 million reduction in net debt “The second quarter of 2023 shows a continuation of our Patient Direct segment’s exceptional performance, with another quarter of double-digit growth and...

Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the second quarter of 2023 on Friday, August 4, 2023, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to...

Owens & Minor, Inc . (NYSE: OMI), a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services, announced today that Ed Pesicka, the Company’s President and CEO, and Jonathan Leon, the Company’s SVP, Corporate Treasurer, will be hosting one-on-one meetings with investors at the UBS Healthcare Services Conference in Chatham, Massachusetts on Tuesday, June 27, 2023. About Owens & Minor Owens & Minor, Inc. (NYSE: OMI) is...

Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services, announced today that Ed Pesicka, the Company’s President and CEO, and Alex Bruni, the Company’s Chief Financial Officer, will be participating in a webcasted fireside chat at 1:00 p.m. Eastern Daylight Time on Tuesday, May 9, 2023 at BofA Securities’ 2023 Health Care Conference in Las Vegas, Nevada. Owens & Minor is also...

Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2023. Key Highlights: Consolidated revenue of $2.5 billion in the first quarter Net loss per common share of $(0.32) and adjusted net income per common share of $0.05 in the first quarter $158 million of operating cash flow generated in the first quarter $117 million in debt pay down 2023 outlook reflects strong financial performance in the Patient Direct segment, progress made in operational...

Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2023 on Friday, May 5, 2023, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access...

Owens & Minor, Inc. (NYSE: OMI) announced today that executive leadership will participate in a fireside chat at the upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference. The discussion will take place on Thursday, March 2 at 8:45 a.m. Eastern Time. Please visit the investor relations page of the Owens & Minor website available at investors.owens-minor.com/events-presentations/ at least ten minutes in advance to register for the live webcast of the discussion. A replay of the...

Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the fourth quarter and the year ended December 31, 2022, as summarized in the table below. “Our Patient Direct segment capped a fantastic year with another strong quarter, and I am pleased that our medical distribution division continues to perform well, retaining and winning new business. However, overall fourth-quarter results showed that we need to move quickly to offset volume decline, cost and pricing headwinds,...